Antonio Maraver Selected Research

Antonio Maraver Research Topics

13	Neoplasms (Cancer) 01/2022 - 07/2007
4	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
3	Neoplasm Metastasis (Metastasis) 05/2021 - 01/2012
2	Adenocarcinoma of Lung 01/2020 - 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Carcinogenesis 11/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Cachexia 01/2020
1	Opportunistic Infections (Opportunistic Infection) 01/2020
1	Disease Progression 01/2020
1	Hypertension (High Blood Pressure) 04/2015
1	Cardiomegaly (Heart Hypertrophy) 04/2015
1	Carcinoma (Carcinomatosis) 08/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2012

3	osimertinibIBA 07/2021 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 07/2007
2	ErbB Receptors (EGF Receptor)IBA 07/2021 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 07/2021 - 01/2020
2	Therapeutic UsesIBA 01/2020 - 08/2012
2	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 04/2015 - 08/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Phenobarbital (Luminal)FDA Link 11/2021
1	CrizotinibIBA 07/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021
1	pembrolizumabIBA 05/2021
1	demcizumabIBA 01/2021
1	LigandsIBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2020
1	ElementsIBA 01/2020
1	PlatinumIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Cetuximab (Erbitux)FDA Link 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Muscle Proteins (Muscle Protein)IBA 08/2016
1	Troponin IIBA 08/2016
1	Angiotensin IIIBA 04/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 08/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	MicroRNAs (MicroRNA)IBA 01/2012
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2008